ISIS Pharmaceuticals Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-17

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Isis Pharmaceuticals is the pioneer in antisense drug discovery and development technology. Antisense drugs are short, chemically-modified complementary nucleotide chains that hybridize to a specific complementary area of mRNA. The company has a pipeline of 17 antisense drugs in clinical and preclinical development.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Isis is focused on the discovery and development of antisense for diseases such as cancer, cardiovascular disease and central nervous system. Although the company's only approved product Vitravene is no longer marketed, it has boosted the chances of other antisense drugs getting approved and accepted.

    Isis derives its revenues from royalties and from collaborative agreements consisting primarily of the milestone payments and cost-sharing payments to develop its products with other pharmaceutical companies. The company's total revenues decreased at a CAGR of -26% during 2002-2006, from $80 million to $24 million.

    It is forecasted that Isis would record an absolute growth of +$119 million with sales of $25 million in 2006 increasing to $144 million in 2010, growing at a CAGR of 37%.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: isis pharma pharmaceuticals uk isispharma products pharmaceutical company vitravene mipomersen

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.